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Abstract. Objective: Electrical impedance tomography (EIT) shows potential for
radiation-free and noninvasive hemodynamic monitoring. However, many factors
degrade the accuracy and repeatability of these measurements. Our goal is to estimate
the impact of this variability on EIT-based monitoring of two important central
hemodynamic parameters: stroke volume (SV) and pulmonary artery pressure (PAP).
Approach: We performed simulations on a 4D (3D + t) bioimpedance model of a
human volunteer to study the influence of four potential confounding factors (electrode
belt displacement, electrode detachment, changes in hematocrit and lung air volume)
on the performance of EIT-based SV and PAP estimation. Results were used to
estimate how these factors affect EIT measures of either absolute values or relative
changes (i.e. trending).
Main results: Our findings reveal that absolute measurement of SV via EIT is very
sensitive to electrode belt displacements and lung conductivity changes. Nonetheless,
the trending ability of SV EIT might be a promising alternative. The timing-
based measurement of PAP is more robust to lung conductivity changes but sensitive
to longitudinal belt displacements at severe hypertensive levels and to rotational
displacements (independent of the PAP level).
Significance: We identify and quantify challenges of EIT-based SV and PAP
monitoring. These are, absolute SV via EIT is challenging but trending is feasible,
while both absolute and trending of PAP via EIT are mostly impaired by belt
displacements.
Keywords: electrical impedance tomography (EIT), stroke volume (SV), cardiac output
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(CO), pulmonary artery pressure (PAP), bioimpedance model, simulations
1. Introduction
Since cardiovascular diseases are the major cause of death worldwide (WHO 2011), their
early diagnosis and treatment is of great interest. Reliable diagnosis requires devices
which allow for the accurate and harmless measurement of hemodynamic parameters to
assess the health of the cardiovascular system. However, the clinical reference method
for the measurement of central hemodynamic parameters – such as pulmonary artery
pressure (PAP) or stroke volume (SV) – requires right heart catheterization and is known
to cause complications without decreasing mortality (Harvey et al. 2005). While many
alternative noninvasive approaches exist for SV monitoring, none of these have proven to
be accurate enough (Joosten et al. 2017). On the other hand, the noninvasive assessment
of PAP can only be performed via transthoracic echocardiography, which requires
qualified personnel and is impractical for continuous measurements (Proenc¸a 2017).
In view of overcoming these limitations, electrical impedance tomography (EIT) has
been investigated in previous studies as a low-cost and radiation-free medical imaging
modality for the noninvasive and continuous monitoring of SV (Vonk Noordegraaf
et al. 2000, Pikkemaat et al. 2014) and PAP (Proenc¸a et al. 2016, Proenc¸a 2017).
Electrical impedance tomography (EIT) calculates the distribution of intra-thoracic
impedance using measurements at electrodes placed on the chest surface through which
small electrical currents are applied. EIT shows promise as a modality for noninvasive
medical monitoring (Frerichs et al. 2017, Holder 2005). The most common thoracic
application of EIT is for assessment of ventilation, as changes in alveolar air volume
lead to changes in electrical impedance. EIT is also sensitive to cardiovascular activity.
However, such monitoring is more challenging: First, the cardiac-related impedance
changes are about one order of magnitude smaller than ventilation-related changes, and
signal processing techniques must be used to separate them. Second, the exact origin of
these cardiosynchronous signals remains unclear (Adler et al. 2017). Thus, for example,
the EIT signal during systole has contributions from SV as well as other effects such
as heart motion (Proenc¸a et al. 2015) and flow-induced reorientation of red blood cells
(Gaw 2010). In this case, the EIT signal will not change in proportion to SV, if the
magnitude of the other contributions are not also proportional.
EIT-based assessment of numerous hemodynamic parameters have been reported:
systemic (Sola` et al. 2011) and pulmonary artery pressure (Proenc¸a et al. 2016, Proenc¸a
2017), stroke volume (Vonk Noordegraaf et al. 2000, Pikkemaat et al. 2014), stroke
volume variations (Maisch et al. 2011), pulmonary perfusion (Borges et al. 2012, Frerichs
et al. 2009, Nguyen et al. 2012). Some studies describe limitations and challenges in
cardiovascular EIT monitoring, in particular concerning the monitoring of SV. Patterson
et al. (2001) concluded the cardiac EIT signal depends strongly on electrode position,
lung volume and posture, in healthy volunteers. In pig experiments, Pikkemaat et al.
(2014) observed variations in the subject-specific scaling of the cardiac EIT signal, which
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were interpreted to stem from lung volume or heart and belt position. In a simulation
study, Arshad et al. (2016) showed a strong respiration-related dependence in the EIT
heart signal.
As accurate monitoring results are of importance for reliable diagnostics, our goal
in this paper is to estimate the impact of these challenges on EIT-based hemodynamic
monitoring. Specifically we seek to estimate the amount of uncertainty introduced
into EIT-based hemodynamic parameters due to the variability in realistic clinical and
ambulatory scenarios. To do so, we first list potential confounding factors and then
study how seriously these factors affect the estimation of two hemodynamic parameters:
stroke volume (SV), and pulmonary artery pressure (PAP). The four confounding factors
selected were: (1) electrode belt displacement, (2) electrode detachment, (3) changes in
hematocrit, and (4) changes in lung air volume.
In the current study we perform simulations on a 4D (3D+t) thoracic bioimpedance
model – representing cardiovascular changes of a healthy human volunteer. This allows
a systematic and individual investigation of potential confounding factors, which is
practically impossible in real measurements. While the few limitations reported for
SV monitoring via EIT are mainly based on observations from real measurements
(as mentioned above), no such work is currently available at all for PAP monitoring.
Thus, to the best of our knowledge, this is the first work systematically identifying
and quantifying potential challenges for EIT-based SV and PAP monitoring, based on
simulations on a bioimpedance model.
In section 2 we first present the bioimpedance model followed by a description of
the simulations and the steps performed for signal processing and data analysis. The
results are presented and discussed in section 3.
2. Methods
In the following we first describe the dynamic bioimpedance model used to perform EIT
simulations. Next, we list potential confounding factors and describe the four potentially
harmful ones investigated, together with other simulation parameters. Then we explain
the signal processing steps used to estimate the two hemodynamic parameters (SV and
PAP) from EIT image sequences. Finally, we describe the analysis applied to evaluate
and quantify the decrease in performance resulting from each of the confounding factors.
2.1. Dynamic Bioimpedance Model
2.1.1. Base Model In order to simulate different hemodynamic scenarios, a dynamic
bioimpedance model was created. This model is shown in Figure 1 and represents a
4D electrical conductivity distribution of a human thorax during expiratory breath-hold
containing models of the heart, aorta and lungs. These models are based on magnetic
resonance imaging (MRI) recordings performed on a human volunteer (62 kg, 178 cm,
28 years old). The model allows to virtually measure cardiovascular EIT with many
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Figure 1. Block diagram of the simulation framework and the possible parameters
of the bioimpedance model: heart rate (HR), stroke volume (SV), hematocrit (Ht),
pulmonary artery pressure (PAP), lung filling factor (FF). The simulEITor framework
further allows the simulation of electrode displacement and detachment.
PAP Estimation
SV Estimation
Lung ROI 
Detection
Heart ROI 
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Heart Amplitude
Calibration
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Figure 2. Block diagram of the analysis used to estimate PAP and SV from EIT
image sequences.
different configurations, i.e. varying number of electrodes and their position or different
voltage measurement and current injection patterns. For the present work five different
EIT belts – each comprised of 32 electrodes – were applied on a transversal plane
located at different levels along the craniocaudal axis as follows (see also Figure 1): (1)
the TM (transversal middle) belt was placed at the average level of the heart, which is
in between the 9-th and 10-th thoracic vertebra; The belts (2) TH (transversal high)
and (3) TL (transversal low) were placed 3.5 cm higher and lower than TM, which is
at the level of the 8-th (for TH) or in between the 10-th and 11-th (for TL) thoracic
vertebra; The remaining two belts, (4) TMH (transversal middle-high) and (5) TLM
(transversal low-middle), were placed 1.75 cm higher and lower than TM, corresponding
to the 9-th (for TMH) or 10-th (for TLM) thoracic vertebra level. All simulations were
performed on each belt of 32 electrodes using a bipolar stimulation pattern with four
inactive electrodes between the two ones actively measuring voltage/injecting current,
also known as skip 4 (Gaggero et al. 2012).
The model initially presented in (Braun et al. 2015a) was extended – as described
in the following – with a more detailed heart (section 2.1.2) and pulmonary model
(section 2.1.3). As in the original model (Braun et al. 2015a), skeletal muscle, fat and
bones were not modeled individually but included as one intra-thoracic background
conductivity composed of a mixture of 48 % muscle, 47 % fat and 5 % bone.
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2.1.2. Heart Model The heart is represented by a 4D surface model of its four chambers:
left/right atria/ventricles. For each of these structures a dynamic representation of
its inner and outer boundaries (i.e. the endo- and epicardium) were segmented from
dynamic MRI scans as described in (Braun et al. 2015b). This model was further
improved in view of altering the ventricular volumes, i.e. to obtain different SVs. To
this end, the volumes of the left (LV) and right ventricle (RV) were artificially modified
over the entire cardiac cycle as described hereafter.
For both ventricular structures a median line was defined ranging from its
apex to the center of its semilunar valve at end diastole. Then, to alternate the
ventricular volume, all vertices of the corresponding model were displaced radially
to the aforementioned median line. This leads to either shrinking or dilating of the
corresponding ventricle. To obtain a specific ventricular volume the abovementioned
procedure is applied in an iterative manner until the volume of the scaled ventricles
matches the desired volume. Besides, for each iterative step, endocardial structure is
scaled first and then the epicardial structure is adapted keeping a constant volume
difference between the two structures and thus ensuring the quasi incompressibility of
myocardial tissue (Vossoughi et al. 1980). In the present work, the SV of the left and
right heart were defined to be identical: SVR = EDVR−ESVR = SVL = EDVL−ESVL
(with EDV and ESV as the end diastolic and end systolic volumes, respectively).
Besides, a constant difference of EDVR − EDVL = 28 mL was set to account for the
observed difference between left and right ventricular volume.
2.1.3. Pulmonary Model The spatio-temporal representation of the electrical
conductivity in the lungs is based on a detailed model of the pulmonary circulation
as further explained in (Proenc¸a 2017, Proenc¸a et al. 2017). This model allows the
simulation of different levels of pulmonary artery pressure (PAP) and various types of
pulmonary hypertensive conditions: PAH (pulmonary arterial hypertension), PHLHD
(pulmonary hypertension due to left heart disease), HAPE (high altitude pulmonary
edema), CTEPH (chronic thromboembolic pulmonary hypertension) (Proenc¸a 2017,
Proenc¸a et al. 2017).
2.2. Simulations Performed
2.2.1. Physiological Parameters In view of mimicking physiological meaningful
SV variations, different cases of changes in preload, afterload and inotropy
were simulated. Initially proposed in (Proenc¸a et al. 2015, Proenc¸a 2017) and
adapted to the current model, this lead to these eleven values of SVRef =
[46.0, 53.4, 60.7, 60.8, 61.3, 68.0, 74.2, 74.7, 80.8, 93.5, 106.3] mL.
Moreover, for each of the four pulmonary pathologies supported by the current
model, five levels of disease severity were simulated and compared to the normal
– non-pathological – state corresponding to the following six levels of PAPRef =
[14, 24, 34, 44, 54, 64] mmHg.
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2.2.2. Investigations on Potential Confounding Factors When measuring EIT in
realistic clinical or ambulatory scenarios, various factors – external (i.e. affecting the
EIT system) or internal (i.e. affecting the human body under measurement) – can alter
the EIT data measured and thus also the SV and PAP estimates derived thereof.
In the following we first attempt to elucidate possible factors affecting
cardiovascular EIT measurements. These are: (1) electrode displacement: shifting
during a measurement or misplacement between different measurements; (2) issues with
electrode contact, e.g. detachment or drying out of contact gel; (3) changes in blood
conductivity due to changes in hematocrit; (4) changes in lung conductivity due to
respiration, liquid redistribution, extra-vascular lung water, etc.; (5) respiration-induced
thorax excursion, displacement and deformation of heart, lungs and other tissues;
(6) posture- and gravity-induced changes such as organ and liquid redistribution;
(7) electronic noise and disturbances; (8) impedance changes due to the pulsatile
reorientation of red blood cells (Gaw 2010) or other anisotropic structures, e.g. the
myocardium (Adler et al. 2017).
While (5) and (7) can be – at least partly – reduced and averaged with the proper
filtering technique (i.e. ECG-gated ensemble averaging), (6) might be less important
when targeting bedside EIT. Due to its complexity and the assumed equally importance
of the other factors, (8) was not investigated in the present work.
The remaining four potential confounding factors (1), (2), (3), and (4) were studied
and are described in more detail hereafter:
(i) Electrode belt displacement: When using an EIT system where all electrodes
are included in a belt, the whole of electrodes can be displaced in longitudinal
(up/down) direction or rotated (left/right). This problem can occur during the
same measurement or between different measurements where the belt needs to be
reapplied – without necessarily having the knowledge of the exact belt position of
the preceding measurement. For an EIT system based on gel electrodes only the
latter can apply.
The TM belt (located at the height of the ventricles, see Figure 1) is considered
as the ”baseline” belt placement to which all the other displacements are being
compared to. By using the other four belts (TL, TLM, TMH, TH) a up- and
downward displacements of 1.75 and 3.5 cm were simulated.
For rotational belt displacements, two levels of magnitude were simulated by
shifting the belt by 0.5 or 1.0 electrode spacing to the left/right, respectively. At the
present thorax circumference of about 90 cm these shifts correspond to rotational
displacements of 1.4 and 2.8 cm, respectively.
(ii) Electrode detachment: For various reasons (movement of the patient via internal
or external influence, drying of electrode gel, pectus excavatum, etc.) the contact of
certain EIT electrodes with the human body can be or become bad. To ensure
reliable EIT images, the measurements related to these electrodes need to be
removed prior to reconstruction. To this end, we simulated the detachment of each
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single electrode and all possible pairs of electrodes, leading to
(
32
1
)
+
(
32
2
)
= 528
combinations. Failing electrodes are compensated during EIT image reconstruction
with the algorithm described in (Mamatjan et al. 2013).
(iii) Lung air volume changes: Due to respiration, intra-thoracic conductivity
distribution changes significantly between in- and expiration. To this end, we
simulated four different lung air volume levels: (1) forced expiration, (2) expiration,
(3) between in- and expiration, and (4) inspiration. These four levels, corresponding
to filling factors of FF = [1.3, 2.0, 3.0, 4.8], were simulated using lung alveolar tissue
conductivities of σL = [0.12, 0.10, 0.08, 0.06]
S
m
according to (Roth et al. 2015).
Even though respiratory activity normally involves other changes (i.e. deformation
and/or displacement of lungs, heart and thorax) the current model simulates breath-
hold and does therefore only support changes in σL.
(iv) Hematocrit changes: The percentage of red blood cells in the blood – known
as hematocrit – does significantly influence the electrical conductivity of blood
σB. To investigate the influence of hematocrit-related changes, we simulated five
physiological hematocrit levels (Ht = [35, 40, 45, 50, 55] %), which were transformed
to the corresponding blood conductivity levels (σB = [0.87, 0.78, 0.70, 0.63, 0.56]
S
m
)
according to (Geddes & Sadler 1973).
2.2.3. EIT Image Reconstruction Following the pipeline illustrated in Figure 1: the raw
data resulting from simulations were reconstructed into EIT images using the GREIT
algorithm (Adler et al. 2009) with the recommended parameters and a noise figure of
NF = 0.5. The reconstruction is based on a coarse version of the forward model with
uniform conductivity and uses the TM belt placement.
2.3. Hemodynamic Parameter Estimation
In this section we describe the signal processing approaches to estimate SV and PAP
from EIT image sequences.
2.3.1. Stroke Volume (SV) Estimation The present approach is based on hypothesis
that the amplitude of the EIT heart signal is proportional to the SV, as also reported
by other groups (Pikkemaat et al. 2014, Vonk Noordegraaf et al. 2000). The algorithm
used is fully automatic and consists of three steps also illustrated in Figure 2: (1)
determination of the heart ROI, (2) estimation of the heart sum signal amplitude ∆σH
as SV surrogate measure, and (3) the calibration function.
The heart ROI is determined as follows. First, each pixel is assigned to the heart
or non-heart region according to its phase at cardiac frequency (similar to the lung
ROI detection in (Proenc¸a et al. 2016, Proenc¸a 2017)). Second, the potential timing of
end systole is identified as the minimum of the sum signal of all potential heart pixels.
Thirdly, a difference image (end diastole minus end systole) is calculated. Finally, the
heart region is identified as the biggest region with positive amplitude in this difference
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image where all pixels with an amplitude below an automatically determined threshold
(Otsu 1979) got removed. The heart amplitude ∆σH is then computed from the sum
signal in the aforementioned heart ROI as the amplitude between end diastole and end
systole. The calibration transforming ∆σH from arbitrary units into SVEIT expressed
in mL is described later in section 2.4.
2.3.2. Pulmonary Artery Pressure (PAP) Estimation Our approach to measure PAP
via EIT is based on the so-called pulse wave velocity principle and described in detail in
(Proenc¸a et al. 2016, Proenc¸a 2017). In short, we assess the arrival of the blood pressure
pulse in the distal lung region by estimating the so-called pulse transit time (PTT) – a
surrogate measure for PAP having a negative exponential relationship: PTT ∝ e−a·PAP.
The algorithm used is fully automatic and consists of three steps also illustrated in
Figure 2: (1) determination of the lung region of interest (ROI), (2) pixel-wise PTT
estimation using Chiu’s method (Chiu et al. 1991) followed by outlier removal and global
PTT calculation, and (3) the calibration transforming PTT into PAPEIT expressed in
mmHg (described later in section 2.4). More details regarding this approach and the
algorithm can be found in (Proenc¸a et al. 2016, Proenc¸a 2017, Proenc¸a et al. 2017).
2.4. Analysis and Performance Evaluation
To investigate the performance of the EIT-based SV and PAP estimates, we need to
define figures of merit to quantitatively assess the errors caused by the aforementioned
confounding factors. The influence of each of the confounding factors is assessed by
comparing to the baseline configuration: TM belt, no belt displacement, no detached
electrode, σL = 0.10
S
m
(FF = 2.0) and σB = 0.70
S
m
(Ht = 45 %).
2.4.1. Stroke Volume The conductivity amplitude in the heart region ∆σH (computed
as described in section 2.3.1), is transformed into SV values expressed in mL as follows.
We first compute the linear fit (fH(x) = a · x + b) between the simulated SV values
SVRef and the EIT-derived heart-amplitude ∆σH of the baseline configuration. All ∆σH
are then transformed into SV values with exactly the same calibration function, i.e.
SVEIT = fH(∆σH). This allows to investigate the influence of the different confounding
factors while assuming an initial calibration of the EIT vs a SV reference.
In a first analysis (Analysis I), based on Bland-Altman analysis, we quantify the
absolute Abs and relative error Rel between the estimate SVEIT of the current vs the
baseline configuration. Besides, the correlation coefficient r between SVEIT and SVRef
is computed. Measurements are considered as reliable if the 95 % confidence interval of
Rel does not exceed ±10 %, which is one third of the ±30 % error reported for invasive
thermodilution and thus assumes averaging of at least three reference measurements as
typically done in practice (Critchley 2013).
In a second analysis (Analysis II), we analyze the trending ability of the EIT-
based SV values, that is the ability of SVEIT to track changes in SV, but not absolute
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values of SV. To this end, we first compute the changes of SV from an initial starting
measurement and obtain the SV changes ∆SVEIT and ∆SVRef, respectively. Then we
plot ∆SVEIT vs ∆SVRef in a 4-quadrant plot, a common methodology to asses trending
ability (Critchley 2013, Saugel et al. 2015). The 4-quadrant plot was chosen over the
polar plot because of its more intuitive interpretability and the fact that only noisy but
not the most discordant measurements are excluded (Saugel et al. 2015). As suggested
in (Saugel et al. 2015), we further quantify the trending ability by means of (1) the
concordance rate CR and (2) the angular error α. (1) CR represents the percentage
of measurements where ∆SVEIT and ∆SVRef change in the same direction, i.e. lie in
the 1st and 3rd quadrant; (2) the angular error is defined as the angle between the
identity line (∆SVEIT = ∆SVRef) and the line from the origin to the point (∆SVRef,
∆SVEIT). According to (Critchley et al. 2011) the following criteria are required to
ensure acceptable trending ability: CR > 92 %, mean angular error < ±5◦, confidence
interval of angular error < ±30◦.
2.4.2. Pulmonary Artery Pressure The pulmonary pulse transit time PTT (computed
as described in section 2.3.2), is transformed into PAP values expressed in mmHg as
follows. We first compute the best fit (f iP (x) = a · log (x− b) + c) between the simulated
PAPRef values and the EIT-derived pulmonary PTT of the baseline configuration. A
different calibration function is used for each of the four PAP pathologies simulated:
PAPEIT = f
i
P (PTT),∀ i ∈ [1, 4]. Since at higher PAP levels, small deviations of PTT can
already lead to high errors in PAP, all PAPEIT values above an unphysiological threshold
of 100 mmHg were considered as invalid. All PTT values are then transformed into PAP
values with the pathology-specific calibration function, i.e. PAPEIT = f
i
P (PTT).
In the first PAP-related analysis (Analysis III), similar to the first SV analysis
(Analysis I), we quantified the absolute Abs and relative error Rel by means of Bland-
Altman analysis between PAPEIT of the current vs the baseline configuration. Moreover,
the correlation coefficient r between PAPEIT and PAPRef is computed. PAPEIT estimates
are considered as sufficiently accurate if the 95 % confidence interval of Abs falls within
±10 mmHg (Fisher et al. 2009), which is roughly the achievable accuracy of the current
noninvasive gold standard for PAP estimation, namely transthoracic echocardiography.
In the last analysis (Analysis IV), the trending ability of PAPEIT was assessed.
This was done analogously to Analysis II, i.e. concordance rate CR and the angular
error α were analyzed between ∆PAPEIT and ∆PAPRef. The same acceptance criteria
(CR > 92 %, mean angular error < ±5◦, confidence interval of angular error < ±30◦) as
in Analysis II were applied to PAP. As these limits are designed for SV measurements
(Critchley 2013), they might be too conservative, but – to the best of our knowledge –
no such limits are specified for (pulmonary) blood pressure measurements.
Page 9 of 25 AUTHOR SUBMITTED MANUSCRIPT - PMEA-102128.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
ce
pt
d M
an
us
cri
pt
Limitations and Challenges of EIT-Based Monitoring of SV and PAP 10
3. Results and Discussion
3.1. Analysis I - Absolute SV
3.1.1. Belt Displacement The influence of up/down and left/right electrode belt
displacement are shown in Figure 3 and the resulting errors are listed in Table 1. It
can be observed that after all types of belt displacement SVEIT still remains highly
correlated with SVRef (r ≥ 0.99 in Table 1, which is in line with other simulation-based
studies (Dinkelbach & Stender 2015, Murphy et al. 2015).
However, the up- and downwards belt shifts introduce a significant bias in SVEIT,
i.e. a downwards shift leads to an increase and a upwards shift to a decrease of SVEIT,
respectively. This can be explained by the increase of ventricular and decrease of the
pulmonary signal contribution when shifting the belt downwards, whereas the opposite
applies for an upwards shift. This bias can get as high as 28.2 % and as low as −29.2 %
when shifting the belt downwards or upwards by 3.5 cm, respectively.
In contrast, the errors caused by the rotational belt shifts are smaller: i.e. a
leftwards shift of 2.8 cm results in a bias of 13.4 % whereas the bias for rightwards shifts
is highest at 1.4 cm with only −5.3 %. The asymmetry of errors observed between left
and right shifts is assumed to be due to the non-central position of the heart and the
uneven distribution of lung volume between left and right.
Figure 3. Influence on SVEIT by (a) up/down and (b) left/right electrode belt
displacements. The relationship of reference SV (SVRef) and EIT-based SV estimates
(SVEIT) is shown in the upper plots. The lower plots depict the relative error between
SVEIT and the baseline configuration.
3.1.2. Electrode Detachment The relative errors in SVRef resulting from the
detachment of one or two electrodes are shown in Figure 4. The errors were calculated
over the 11 SVRef simulated and are visualized per electrode to show the influence for
each of the electrodes individually. Table 2 further lists the error statistics for a selection
of eight electrodes when involved in the removal of two electrodes.
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Table 1. Absolute error (Abs), relative error (Rel) and correlation coefficient (r)
of SVEIT for different electrode belt displacements when compared to the baseline
configuration. Cell shadings indicate whether the acceptance criteria (see section 2.4.1)
are met (green) or not (red).
Up/Down Displacement Left/Right Displacement
↑ 3.5 cm ↑ 1.8 cm ↓ 1.8 cm ↓ 3.5 cm ← 2.8 cm ← 1.4 cm → 1.4 cm → 2.8 cm
Abs (mL) −20.9± 6.1 −11.2± 3.1 10.7± 2.4 19.7± 3.7 9.6± 2.7 5.0± 1.4 −3.8± 1.2 −2.2± 0.5
Rel (%) −29.2± 1.6 −15.6± 0.8 15.2± 0.7 28.2± 2.1 13.4± 1.0 7.1± 0.7 −5.3± 0.8 −3.4± 1.3
r 0.9987 0.9993 0.9995 0.9984 0.9995 0.9998 0.9993 0.9990
The overall error is −1.08±1.23 % (−0.78±0.95 mL) when removing one electrode
(Figure 4a) and −2.28 ± 1.79 % (−1.66 ± 1.44 mL) when removing two electrodes
(Figure 4c), respectively. However, it has to be noted that detaching electrodes (1 to 4,
31 and 32) located in the ventral left region – close to the heart – results in higher errors
(see also Figure 4b). These findings highlight the importance of a good electrode contact
in the ventral region. In practice this can be quite challenging, especially for EIT systems
having the electrodes included in a belt, where electrode contact is often impaired in
the sternum region (e.g. pectus excavatum). This issue might be party circumvented
by using more sophisticated simulation and measurement patterns or even by adapting
them in real-time.
1 5
9
131721
25
29
Figure 4. Relative error of SVEIT resulting from the detachment of (a) a single
electrode or (c) all possible pairs of electrodes. The error statistics shown are calculated
over the 11 SV states simulated. The transversal EIT plane in (b) shows the position
of the 32 electrodes (in green) and highlights the ones with higher errors (in red).
Table 2. Absolute error (Abs), relative error (Rel) and correlation coefficient (r) of
SVEIT resulting from the detachment of 2 electrodes when compared to the baseline
configuration. Cell shadings indicate whether the acceptance criteria (see section 2.4.1)
are met (green) or not (red).
Elec. 1 Elec. 5 Elec. 9 Elec. 13 Elec. 17 Elec. 21 Elec. 25 Elec. 29
Abs (mL) −3.4± 1.4 −2.1± 1.4 −1.5± 1.2 −1.3± 1.0 −1.1± 1.0 −1.0± 1.0 −1.2± 1.1 −1.1± 1.1
Rel (%) −4.8± 1.4 −2.9± 1.6 −2.1± 1.5 −1.7± 1.3 −1.5± 1.3 −1.3± 1.3 −1.6± 1.3 −1.6± 1.4
r 0.9975 0.9968 0.9973 0.9978 0.9979 0.9978 0.9977 0.9976
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3.1.3. Changes in Hematocrit and Lung Air Volume Figure 5a shows how changes in
hematocrit influence SVEIT. The corresponding errors are listed in Table 3. An increase
in blood conductivity σB – resulting from a decrease in hematocrit – leads to a higher
SVEIT and in return, a decrease in σB to a lower SVEIT. Nevertheless, the errors remain
rather low, i.e. over the entire physiological range of Ht from 35 to 55 %, the relative
bias changes only from 2.3 % to −3.4 %.
In contrast, changes in lung alveolar tissue conductivity σL – resulting from changes
in lung air volume between normal inspiration and forced expiration – have a higher
influence on SVEIT. This is depicted in Figure 5b and also listed in Table 3. Normal
inspiration (σL = 0.06
S
m
) compared to normal expiration (baseline state) introduces a
relative bias of 8.0 %. On the other hand, full expiration (σL = 0.12
S
m
) lowers the bias
to −3.2 %.
Figure 5. Influence on SVEIT by changes in (a) hematocrit and (b) lung air volume.
The relationship of reference SV (SVRef) and EIT-based SV estimates (SVEIT) is shown
in the upper plots. The lower plots depict the relative error between SVEIT and the
baseline configuration.
Table 3. Absolute error (Abs), relative error (Rel) and correlation coefficient (r) of
SVEIT for changes in hematocrit and lung air volume when compared to the baseline
configuration. Cell shadings indicate whether the acceptance criteria (see section 2.4.1)
are met (green) or not (red).
Hematocrit Changes Lung Air Volume Changes
σB = 0.56 σB = 0.63 σB = 0.78 σB = 0.87 σL = 0.06 σL = 0.08 σL = 0.12
(Ht = 55%) (Ht = 50%) (Ht = 40%) (Ht = 35%) (FF = 4.8) (FF = 3.0) (FF = 1.3)
Abs (mL) −2.6± 1.4 −1.2± 0.7 1.0± 0.6 1.8± 1.1 6.1± 3.9 2.9± 1.7 −2.4± 1.4
Rel (%) −3.4± 1.0 −1.5± 0.5 1.4± 0.5 2.3± 1.0 8.0± 3.3 3.9± 1.4 −3.2± 1.2
r 0.9997 0.9996 0.9995 0.9995 0.9996 0.9997 0.9993
3.1.4. Summary Among the potential confounding factors investigated for absolute
SV measurement, we could show that up- and downwards electrode displacements have
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the highest influence in terms of relative error, i.e. a shift of 1.8 or 3.5 cm can already
introduce a relative error bias in the magnitude of about 15 or 30 %, respectively. These
findings call into question the feasibility of absolute SV measurements by means of single
plane (2D) EIT without recalibrating upon each displacement or reattachment of the
EIT belt. The use of two EIT planes (3D) (Grychtol et al. 2016) might help to reduce
the sensitivity on belt displacements in the longitudinal direction, and thus reduce the
error on SV estimation in case of belt shifts. However, a subject-specific calibration
is still necessary, as the absolute heart impedance signal remains influenced by various
other factors (thorax morphology, lung conductivity, etc.), as also shown in experimental
findings on pigs (Pikkemaat et al. 2014).
Rotational belt shifts of one electrode spacing (i.e. 2.8 cm) can introduce relative
errors with a bias of up to 13 %. This highlights the importance of a correct
belt placement and the necessity to have an accurate enough reconstruction model
with possibly updating it (in real-time) according to the thorax morphology (Tizzard
et al. 2016).
Furthermore, changes in lung alveolar tissue conductivity σL resulting simply from
a respiratory cycle have shown to introduce a high bias in relative error ranging
from 8 % to −3 % (from normal inspiration to full expiration). The higher the SV
the higher the influence of this effect. This is because – unlike suggested by other
researchers (Pikkemaat et al. 2014, Vonk Noordegraaf et al. 2000) – changes in EIT
heart impedance are not solely related to changes in cardiac blood volume but scaled by
a heart-lung-conductivity contrast and other factors (see Figure 6 for illustration and
detailed explanation). Other factors such as heart displacement due to respiration or
postural changes and changes of σL due to edema, pneumothorax or posture-induced
liquid redistribution were not taken into account but might even worsen the current
results.
These findings reveal further challenges of EIT-based SV monitoring and call for
more detailed and targeted studies to assess the influences of these different confounding
factors to show the extent and the conditions under which EIT-based SV is feasible in
clinical scenarios at all.
The current outcomes are in line with the findings in (Eyuboglu et al. 1988). That
is, absolute SV is hard, but trending should be possible. Therefore, we performed a
second analysis presented in the next section assessing the trending ability of EIT-based
SV.
3.2. Analysis II - Relative SV - Trending
In this section we address the question whether trending of SV via EIT is feasible, i.e.
can we follow the changes in SV over time after an initial calibration with SV0. For the
subsequent analysis the baseline SV was chosen as calibration value (SV0 = 68.0 mL).
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SVEIT ∝ SVReal 𝜎𝐻 − 𝜎𝑃
HLC
− SVMin
Lung Conductivity:
𝜎𝑃 = 𝑓(𝜎𝐿, 𝜎𝐵 , … )
Heart Conductivity:
𝜎𝐻 = 𝑓(𝜎𝐵, 𝜎𝑀, … )
Influences on Heart-Lung-Conductivity Contrast (HLC)
• Lung Air Volume  
↑↑ ⇒ 𝜎𝑃 ↓↓ ⇒ HLC ↑↑ ⇒ SVEIT ↑↑
↓↓ ⇒ 𝜎𝑃 ↑↑ ⇒ HLC ↓↓ ⇒ SVEIT ↓↓
• Hematocrit  
↑↑ ⇒ 𝜎𝐻 ↓↓, 𝜎𝑃 ↓ ⇒ HLC ↓ ⇒ SVEIT ↓
↓↓ ⇒ 𝜎𝐻 ↑↑, 𝜎𝑃 ↑ ⇒ HLC ↑ ⇒ SVEIT ↑
Figure 6. Conceptual explanation of the heart-lung conductivity contrast (HLC)
influencing the EIT-based heart impedance signal used for estimating SVEIT. During
a cardiac cycle heart tissue is spatially replaced by lung tissue and vice versa (black
arrows). These changes in conductivity are assumed to be the main contributor to
the EIT-based heart signal. Unlike sometimes assumed this signal and thus SVEIT
cannot be directly proportional to the real blood volume change SVReal as it is (1)
scaled with the HLC and (2) limited to an inferior level of detection SVMin (due to
ringing and overlapping of other signal sources like the lungs or atria). HLC is defined
as the difference of heart conductivity σH (depending on blood conductivity σB and
myocardial conductivity σM ) and lung conductivity σP (depending on lung alveolar
tissue conductivity σL and blood conductivity σB). An increase in lung air volume
leads to an increase in HLC and thus to an augmented SVEIT, and vice versa. On
the other hand, increasing hematocrit levels (Ht ↑ ⇒ σB ↓) lead to a decrease in
σH and a less strong decrease of σP . The result is a slight decrease in HLC and a
reduced SVEIT. It needs to be stressed out that this remains a simplified explanation
as the heart impedance signal can be influenced by further factors such as heart motion
(Proenc¸a et al. 2015), out-of-(EIT-)plane motion of the heart, σB dependence on blood
flow (Gaw 2010), anisotropy of the myocardium, etc. (Adler et al. 2017).
3.2.1. Belt Displacement The trending ability after up/down and left/right belt
displacement are shown in Figure 7a and Figure 7b, respectively, by means of four
quadrant plots with the corresponding errors listed in Table 4. All concordance rates
CR are at 100 % and thus fulfill the first requirement for trending according to (Critchley
et al. 2011). The second requirement of an angular error bias of less than 5◦ is only
fulfilled for the 1.8 cm downwards shift and all left/right shifts. However, the angular
bias resulting from a 3.5 cm downwards or 1.8 cm upwards shifts are only close above
the threshold and might lead to a sufficient enough trending performance, given that
the CR and the confidence interval of α are well within the acceptable limits.
Table 4. Trending performance by means of angular error (α) and concordance rate
(CR) of SVEIT as influenced by electrode belt displacements. Cell shadings indicate
whether the acceptance criteria (see section 2.4.1) are met (green) or not (red).
Up/Down Displacement Left/Right Displacement
↓ 3.5 cm ↓ 1.8 cm ↑ 1.8 cm ↑ 3.5 cm ← 2.8 cm ← 1.4 cm → 1.4 cm → 2.8 cm
α (
◦) 7.1± 3.0 4.3± 1.8 −5.7± 1.7 −12.5± 1.3 4.8± 1.7 2.4± 1.1 −1.3± 1.6 1.3± 2.1
CR (%) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
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Figure 7. Trending ability of ∆SVEIT vs ∆SVRef as influenced by (a) up/down and
(b) left/right electrode belt displacements. The gray shaded area depicts the zone in
which measurements are considered as unsuitable for trending analysis.
3.2.2. Changes in Hematocrit and Lung Air Volume The α and CR resulting from
changes in hematocrit and lung air volume are shown in Table 5 and do all fulfill the
requirements for trending as specified in section 2.4.1.
Table 5. Trending performance by means of angular error (α) and concordance rate
(CR) of SVEIT as influenced by hematocrit and lung air volume changes. Cell shadings
indicate whether the acceptance criteria (see section 2.4.1) are met (green) or not (red).
Hematocrit Changes Lung Air Volume Changes
σB = 0.56 σB = 0.63 σB = 0.78 σB = 0.87 σL = 0.06 σL = 0.08 σL = 0.12
(Ht = 55%) (Ht = 50%) (Ht = 40%) (Ht = 35%) (FF = 4.8) (FF = 3.0) (FF = 1.3)
α (
◦) −2.2± 1.0 −0.9± 1.2 1.4± 1.4 2.4± 1.7 4.6± 1.6 2.2± 1.0 −1.6± 1.9
CR (%) 100.0 100.0 100.0 100.0 100.0 100.0 100.0
3.2.3. Summary These outcomes give hope for EIT-based trending of SV but at the
same time reveal the strong influence of up/down belt displacements – especially on the
angular bias. Besides, multiple confounding factors could simultaneously deteriorate
SVEIT (e.g. up and left belt displacement together with lung air volume changes) and
thus worsen the current results. To reduce these influences we suggest the use of 3D
EIT and an adaptation of the reconstruction model to the thorax geometry, as alluded
to in the previous section.
3.3. Analysis III - Absolute PAP
3.3.1. Belt Displacement Figure 8 shows the influence of up/down belt displacements
on PAPEIT for the four pathologies simulated. The resulting errors (Abs and Rel) and
the correlation coefficients are given in Table 6.
For most hypertensive levels – i.e. excluding the normal pressure level (PAP =
14 mmHg) – it can be observed that upwards shifts generally lead to an increase in
PAPEIT and downwards shifts to a decrease. This can be explained by the measurement
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Figure 8. PAPEIT estimates influenced by up/down belt displacements shown for
the four pathologies simulated (a) to (d). The top row shows PAPEIT in function
with simulated PAP values. The bottom rows show the resulting relative error when
compared to the baseline configuration.
principle used and the reduced or increased distance to the pulmonary valve – the
origin of the propagating pressure pulse. On the other hand, at the normotensive level,
the relative error is higher for downwards belt shifts as also shown in Table 6. We
hypothesize that at higher PTT levels – as in normotension – the PTT estimation
is more influenced by (ringing of) other signal sources such as the ventricular signal.
This particular signal is stronger the lower the belt is placed, which would explain
the increase in error for downwards shifts. The case of PAH with 1.8 cm upwards shift
shows an exceptionally high error at the highest PAP level. This is due to the non-linear
relationship between PTT and PAPEIT, as small (negative) errors in PTT can lead to
large errors in PAPEIT at severely hypertensive PAP levels. If the most hypertensive level
(PAPRef = 64 mmHg) is excluded from analysis (results not shown) the performances
of all upwards and 1.8 cm downwards shifts fall within the acceptance criteria and only
the 3.5 cm downwards shifts remain out of the acceptable limits.
Figure 9. PAPEIT estimates influenced by left/right belt displacements shown for
the four pathologies simulated (a) to (d). The top row shows PAPEIT in function
with simulated PAP values. The bottom rows show the resulting relative error when
compared to the baseline configuration.
The errors resulting from left/right belt shifts are given in Figure 9 and also listed in
Table 6. In contrast to up/down belt shifts, the left/right shifts generally result in higher
errors of PAPEIT. The magnitude of error caused by slight rotational shifts (1.4 or 2.8
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cm, i.e. 0.5 or 1.0 electrode spacing) are surprising and the reason not fully understood
but clearly linked to the reconstruction model used. A possible explanation is that
small discrepancies of thorax geometries (between the real thorax geometry and the
reconstruction model geometry) result in spatial mixing of the different signal sources,
i.e. a higher contribution of ventricular or atrial signals in the lung region. This in turn
deteriorates the pulmonary signal and estimation of the correct PTT is impaired.
With exception of (b) PHLHD, the other pathologies lead to unphysiological high
PAPEIT values at the highest PAPRef level which were excluded from analysis (marked
with a (†) in Table 6). They thus show a higher error in PAPEIT for leftwards
belt shifts when compared to rightwards shifts, which is consistent with the findings
for SVEIT presented in the previous sections. Again, if the most hypertensive level
(PAPRef = 64 mmHg) is excluded from analysis (results not shown) the performances
improves such that from previously 6, already 12 out of 16 errors fall within the
acceptance criteria defined in section 2.4.2.
Table 6. Absolute error (Abs), relative error (Rel) and correlation coefficient (r)
of PAPEIT for different electrode belt displacements when compared to the baseline
configuration. This is shown for each of the four pathologies: (a) PAH, (b) PHLHD,
(c) HAPE, and (d) CTEPH. Cells marked with (†) indicate that one PAPEIT value
was above the unphysiological threshold of 100 mmHg (see section 2.4.2) and excluded
from analysis. Cell shadings indicate whether the acceptance criteria (see section 2.4.2)
are met (green) or not (red).
Up/Down Displacement Left/Right Displacement
↑ 3.5 cm ↑ 1.8 cm ↓ 1.8 cm ↓ 3.5 cm ← 2.8 cm ← 1.4 cm → 1.4 cm → 2.8 cm
(a)
Abs (mmHg) 2.2± 3.7 5.2± 9.8 −2.8± 4.0 −3.6± 5.6 13.1± 10.1 (†) 7.6± 9.6 2.3± 6.5 3.8± 7.4
Rel (%) 3.1± 6.9 8.1± 15.3 −3.5± 9.7 −2.4± 18.4 37.9± 14.6 (†) 17.3± 12.6 4.2± 12.2 10.5± 19.0
r 0.9916 0.9639 0.9933 0.9969 0.9871 (†) 0.9570 0.9741 0.9690
(b)
Abs (mmHg) 0.3± 1.2 1.3± 2.3 −1.7± 2.6 −3.5± 5.6 4.2± 2.5 1.3± 2.5 2.1± 6.7 −1.7± 4.7
Rel (%) −0.4± 3.8 1.6± 4.5 −1.5± 8.2 −2.3± 18.5 17.3± 17.3 7.0± 9.6 3.2± 13.8 −0.6± 21.8
r 0.9864 0.9818 0.9860 0.9902 0.9766 0.9794 0.9701 0.9739
(c)
Abs (mmHg) 3.0± 3.4 3.4± 3.3 −1.9± 3.3 0.6± 3.3 18.3± 7.3 (†) 8.5± 4.3 −0.5± 2.0 4.2± 4.9
Rel (%) 4.9± 8.0 6.2± 7.5 −0.8± 11.3 8.5± 20.5 57.8± 16.4 (†) 23.5± 7.5 0.4± 10.7 15.6± 23.1
r 0.9953 0.9951 0.9978 0.9986 0.9770 (†) 0.9880 0.9975 0.9775
(d)
Abs (mmHg) 1.6± 2.3 2.0± 2.4 −1.8± 2.7 −3.6± 5.2 5.9± 1.8 (†) 2.8± 1.3 2.0± 4.2 0.0± 3.8
Rel (%) 2.0± 5.9 3.0± 5.5 −1.1± 9.6 −1.6± 21.7 24.5± 20.0 (†) 10.4± 8.9 4.9± 10.2 5.1± 23.4
r 0.9859 0.9861 0.9864 0.9938 0.9664 (†) 0.9819 0.9877 0.9842
3.3.2. Electrode Detachment The error in PAPEIT resulting from removing single or
pairs of electrodes is shown in Figure 10 by the example of the PHLHD pathology.
Table 7 further lists the error statistics for a selection of eight electrodes when involved
in the removal of two electrodes. Detaching one single electrode leads to an error of
1.73± 3.76 % (1.10± 2.26 mmHg) (Figure 10a) and detaching pairs of electrodes to an
error of 2.08± 4.49 % (1.25± 2.65 mmHg) (Figure 10c). The error remains low for all
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electrodes with slightly higher errors for some electrodes located ventrally and on the
right as shown in Figure 10b.
The absolute and relative errors of the other three pathologies are lower (results
not shown) than for the PHLHD pathology shown here.
1 5
9
131721
25
29
Figure 10. Relative error of PAPEIT resulting from the detachment of (a) a single
electrode or (c) all possible pairs of electrodes. The error statistics shown are calculated
over the 6 PAP states simulated for the PHLHD pathology. The transversal EIT plane
in (b) shows the position of the 32 electrodes (in green) and highlights the six electrodes
with highest errors (in red).
Table 7. Absolute error (Abs), relative error (Rel) and correlation coefficient (r) of
PAPEIT resulting from the detachment of 2 electrodes when compared to the baseline
configuration (PHLHD pathology). Cell shadings indicate whether the acceptance
criteria (see section 2.4.2) are met (green) or not (red).
Name Elec. 1 Elec. 5 Elec. 9 Elec. 13 Elec. 17 Elec. 21 Elec. 25 Elec. 29
Abs (mmHg) 1.6± 2.6 0.9± 2.0 1.4± 3.0 1.3± 2.8 0.9± 1.8 0.9± 2.1 1.2± 2.6 1.1± 2.1
Rel (%) 3.8± 5.4 1.3± 3.6 2.1± 4.9 2.0± 4.6 1.4± 3.1 1.4± 3.6 1.7± 4.3 2.4± 3.9
r 0.9754 0.9774 0.9731 0.9733 0.9781 0.9765 0.9746 0.9771
3.3.3. Changes in Hematocrit and Lung Air Volume Figure 11 shows PAPEIT as
influenced by changes in hematocrit and lung air volume by the example of the PHLHD
pathology. The resulting relative errors are also listed in Table 8. While the error
induced by hematocrit changes remains low, lung air volume changes can induce errors
up to −6.7 ± 3.7 %. This could again be explained by the aforementioned influence
of other signal sources deteriorating the PTT estimation. As shown for SV in section
3.1.3, the amplitude of the heart signal is more affected by changes in air volume than by
changes in hematocrit, which would explain the higher errors in PAPEIT for the former
when compare to the latter. Nevertheless, all errors fulfill the acceptance criteria defined
in section 2.4.2.
3.3.4. Summary We could show that for belt displacements PAPEIT is highly sensitive
to small errors of PTT at severe hypertensive levels which translate into high errors in
PAPEIT due to the negative exponential relationship between PTT and PAPEIT. Yet,
when not considering the most hypertensive level at 64 mmHg, PAPEIT is robust to
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Table 8. Absolute error (Abs), relative error (Rel) and correlation coefficient (r) of
PAPEIT for the PHLHD pathology as influenced by changes in hematocrit and lung air
volume when compared to the baseline configuration. Cell shadings indicate whether
the acceptance criteria (see section 2.4.2) are met (green) or not (red).
Hematocrit Changes Lung Air Volume Changes
σB = 0.56 σB = 0.63 σB = 0.78 σB = 0.87 σL = 0.06 σL = 0.08 σL = 0.12
(Ht = 55%) (Ht = 50%) (Ht = 40%) (Ht = 35%) (FF = 4.8) (FF = 3.0) (FF = 1.3)
Abs (mmHg) −0.0± 0.5 −0.2± 0.3 0.0± 0.1 0.1± 0.2 −3.1± 2.2 −1.6± 1.2 1.7± 1.6
Rel (%) −0.1± 1.1 −0.5± 0.7 0.1± 0.4 0.2± 0.6 −6.7± 3.7 −3.3± 2.1 3.5± 2.2
r 0.9858 0.9881 0.9867 0.9859 0.9898 0.9892 0.9816
Figure 11. PAPEIT estimates for PHLHD pathology as influenced by (a) hematocrit,
(b) lung air volume. The top row shows PAPEIT in function with simulated PAP
values. The bottom rows show the resulting relative error when compared to the
baseline configuration.
most up/down belt displacements with the exception of downwards shifts of 3.5 cm for
which the pulmonary signal gets too low and other signal sources prevail. However, the
errors resulting from rotational belt shifts remain surprisingly high and their cause is not
yet fully understood but is assumed to be linked to the mismatch between real thorax
geometry and the one of the reconstruction model. We hypothesize that already small
rotations (0.5 or 1.0 electrode spacing) increase the spatial overlap/mixing of different
signal sources contributing cardiovascular EIT. This issue requires further investigations
which falls out of scope of the current work.
In general, measuring PAPEIT via PTT – a timing-based feature – is more robust
to changes in lung conductivity than the amplitude-based SVEIT estimation. However,
it is sensitive to longitudinal belt displacements at severe hypertensive levels and to
rotational displacements (independent of the PAP level).
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3.4. Analysis IV - Relative PAP - Trending
Analogous to the SV trending analysis (Analysis II in section 3.2) we assess whether
trending of PAPEIT is feasible, i.e. can we follow the changes in PAP over time after an
initial calibration with PAP0. For the subsequent analysis the normotensive PAP level
was chosen as calibration value (PAP0 = 14 mmHg).
3.4.1. Belt Displacement The trending ability after up/down and left/right belt
displacement are shown in Figure 12 by means of four quadrant plots with the
corresponding errors listed in Table 9. While all concordance rates CR are at 100 %
and the confidence interval of α within the < ±30◦ limits, the acceptable threshold of
< ±5◦ for the angular bias is often exceeded.
Figure 12. Trending ability of PAPEIT vs PAPRef as influenced by (Top) up/down
and (Bottom) left/right electrode belt displacements shown for the four pathologies
simulated (a) to (d). The gray shaded area depicts the zone in which measurements
are considered as unsuitable for trending analysis.
3.4.2. Changes in Hematocrit and Lung Air Volume The α and CR resulting from
changes in hematocrit and lung air volume are shown in Table 10 by the example of the
PHLHD pathology. They do all fulfill the requirements specified for trending of PAPEIT.
3.4.3. Summary Considering belt displacements, the high errors observed for absolute
PAP monitoring (mostly for leftwards shifts), also impair the trending ability of PAPEIT
by introducing a high angular bias and require further investigations. Many of the other
belt displacements also result in an angular bias slightly exceeding the < ±5◦ limit and
thus – strictly speaking – do not fulfill the requirements for trending. However, it
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Table 9. Trending performance by means of angular error (α) and concordance
rate (CR) of PAPEIT as influenced by electrode belt displacements. This is shown
for each of the four pathologies: (a) PAH, (b) PHLHD, (c) HAPE, and (d) CTEPH.
Cells marked with (†) indicate that one PAPEIT value was above the unphysiological
threshold of 100 mmHg (see section 2.4.2) and excluded from analysis. Cell shadings
indicate whether the acceptance criteria (see section 2.4.2) are met (green) or not (red).
Up/Down Displacement Left/Right Displacement
↓ 3.5 cm ↓ 1.8 cm ↑ 1.8 cm ↑ 3.5 cm ← 2.8 cm ← 1.4 cm → 1.4 cm → 2.8 cm
(a)
α (
◦) −6.3± 3.2 −2.1± 3.6 6.8± 4.1 5.4± 2.7 10.4± 2.9 (†) 6.4± 4.7 0.8± 4.0 −2.7± 6.8
CR (%) 100.0 100.0 100.0 100.0 100.0 (†) 100.0 100.0 100.0
(b)
α (
◦) −9.1± 2.3 −3.0± 3.1 3.3± 3.2 2.8± 3.1 0.2± 5.3 0.7± 5.0 −2.5± 7.3 −13.3± 10.6
CR (%) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
(c)
α (
◦) −4.5± 1.2 −2.6± 2.5 6.9± 3.0 6.8± 3.2 13.9± 6.2 (†) 7.6± 4.7 −2.9± 2.6 −4.9± 6.3
CR (%) 100.0 100.0 100.0 100.0 100.0 (†) 100.0 100.0 100.0
(d)
α (
◦) −3.9± 4.2 1.6± 5.1 7.7± 5.0 7.7± 5.2 6.5± 7.2 (†) 5.8± 6.2 3.8± 3.1 −3.7± 5.5
CR (%) 100.0 100.0 100.0 100.0 100.0 (†) 100.0 100.0 100.0
Table 10. Trending performance – for the PHLHD pathology – by means of angular
error (α) and concordance rate (CR) of PAPEIT as influenced by hematocrit and lung
air volume changes. Cell shadings indicate whether the acceptance criteria (see section
2.4.2) are met (green) or not (red).
Hematocrit Changes Lung Air Volume Changes
σB = 0.56 σB = 0.63 σB = 0.78 σB = 0.87 σL = 0.06 σL = 0.08 σL = 0.12
(Ht = 55%) (Ht = 50%) (Ht = 40%) (Ht = 35%) (FF = 4.8) (FF = 3.0) (FF = 1.3)
α (
◦) 1.0± 2.9 1.0± 2.8 1.5± 3.1 1.7± 3.2 −2.5± 2.4 −0.6± 2.7 3.0± 3.4
CR (%) 100.0 100.0 100.0 100.0 100.0 100.0 100.0
is questionable whether the acceptance criteria specified – originally proposed for SV
monitoring (Critchley et al. 2011) – are not too strict for the application of noninvasive
PAP monitoring. Depending on the use case, a higher angular bias could be acceptable,
especially when taking into account the other advantages of EIT-based PAP monitoring
(operator independent, fully automatic, continuous application) when compared to the
current noninvasive gold standard (transthoracic echocardiography).
3.5. Limitations and Future Work
The present work is limited in that the hemodynamic bioimpedance model used could
only be partially validated. That is, the findings from simulations on the initial model
regarding EIT-derived PAP estimation (Proenc¸a et al. 2017) have been confirmed by
practical measurements (Proenc¸a et al. 2016). However – although directly derived from
real MRI scans – the heart model allowing for SV changes was not validated against real
EIT measurements. Therefore, we suggest to confirm the current findings by validating
against real EIT measurements for future work.
The bioimpedance model is further limited in that it is solely based on the end
expiratory breath-hold state and no respiration-related displacements and deformations
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can be simulated. More detailed insights might be obtained from a more extensive model
(e.g. (Segars et al. 2010) used in (Murphy et al. 2015)) incorporating thoracic excursions,
lung deformation, heart deformation and displacement (i.e. out of plane motion (Zhang
et al. 2013)) – all modulated by respiration. Moreover, the present SV modifications
were generated artificially. A statistically more representative model covering variations
of multiple individuals might be of advantage. Besides, while skeletal muscles, fat, bones
and skin were only considered in the homogeneous background conductivity (excluding
the skin), these should be modeled as individual structures in the future.
In addition, posture-induced heart displacement and lung liquid distribution, such
as pneumothorax or edema should be studied as they could be additional confounding
factors for EIT based SV monitoring. Even though we have only investigated a part of
all possible confounding factors, we believe to have revealed some important challenges
for SV via EIT mostly due to belt displacements and the heart-lung-conductivity
contrast. Future clinical studies aiming for SVEIT should concentrate on the use of 3D
EIT, constant ventilator settings and posture to avoid most of the confounding factors
observed here from occurring, and then – in a next step – investigate the influence of
each of the factors individually.
In contrary to the amplitude-based feature SVEIT, PAPEIT is measured via PTT –
a timing-based feature (Sola` & Brunner 2012, Sola` et al. 2012). It is therefore not
surprising that EIT-based PAP estimation by means of pulmonary PTT has shown
to be less influenced by changes in hematocrit or lung air volume. Nonetheless,
the strong deteriorating influence resulting from rotational belt displacements require
further investigations and special attention. Moreover, the acceptance criteria specified
for PAP trending, are initially designed for SV trending and might be too restrictive, in
particular the threshold for the angular bias.
4. Conclusion
In this paper, we focus on the problem of uncertainty introduced into EIT-based
hemodynamic measures due to variability in configuration and physiology which occur
in experimental and clinical use. Our goal was to estimate the level of uncertainty in
two important central hemodynamic parameters due to the most important confounding
factors. To this end, we investigated EIT-based hemodynamic monitoring of SV and
PAP, for the four confounding factors potentially deteriorating these measures: (1)
electrode belt displacement, (2) electrode detachment, changes in (3) hematocrit and
(4) lung air volume. Based on simulations on a 4D bioimpedance model, we could show
how seriously each of these factors affect the estimation of relative or absolute PAP and
SV, as also summarized in Table 11.
The amplitude-based feature to assess SV is highly sensitive to – mostly up/down
– belt displacements and to variations in lung air volume. Although these limitations
might be partly overcome by using 3D EIT, our results indicate that the absolute
measurement of SV via EIT remains extremely challenging. Nonetheless, we can
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conclude that the trending ability of SVEIT – that is following changes in SV after
an initial calibration – remains promising.
On the contrary, the timing-based measurement of PAP is more robust to
lung conductivity changes but sensitive to longitudinal belt displacements at severe
hypertensive levels and to rotational displacements (independent of the PAP level).
The latter requires particular attention in further investigations.
The present work is limited in that the hemodynamic bioimpedance model was not
fully validated. Therefore, the current findings remain to be confirmed by means of real
EIT measurements in future work.
Table 11. Findings of the SV and PAP analyses performed for the four confounding
factors investigated. The results are classified according to the percentage falling within
the acceptance criteria: 3 100 % (good); 7 ≥ 75 % (mediocre); 77 < 75 % (bad).
SV PAP
Absolute Relative Absolute Relative
Analysis I Analysis II Analysis III Analysis IV
1. Belt displacement
{
up/down
left/right
77 77 77 77
7 3 77 77
2. Electrode detachment 3 3
3. Hematocrit changes 3 3 3 3
4. Lung air volume changes 77 3 3 3
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